Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
CN Stock MarketDetailed Quotes
Qianjiang Yongan Pharmaceutical (002365)
- 13.06
- -0.29-2.17%
Market Closed May 15 15:00 CST
3.85BMarket Cap111.62P/E (TTM)
13.38High12.91Low82.18KlotVolume13.32Open13.35Prev Close107.91MTurnover3.35%Turnover Ratio171.84P/E (Static)294.68MShares32.0452wk High1.93P/B3.20BFloat Cap12.6252wk Low14.69Limit Up245.29MShs Float32.04Historical High12.02Limit Down3.52%Range %4.02Historical Low0.10Dividend TTM13.13Avg Price41.36KlotAsk0.77%Div Yield TTM100Lot Size36.48KlotBid
Qianjiang Yongan Pharmaceutical (002365) Balance Sheet
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 19.64%253.21M | -28.03%230.59M | 21.58%234.84M | 10.50%267.44M | -13.49%211.65M | -1.77%320.41M | -30.02%193.15M | -9.46%242.04M | 19.48%244.65M | 18.73%326.17M |
| Transactional financial assets | -9.83%622.77M | 14.62%687.89M | 0.05%687.31M | 1.26%663.57M | 4.44%690.65M | -4.75%600.16M | 6.84%686.98M | 1.25%655.33M | 6.73%661.28M | 13.02%630.1M |
| Notes receivable and accounts receivable | 9.76%154.89M | -23.56%122.82M | -6.80%134.82M | -26.70%127.34M | -23.90%141.11M | -6.33%160.68M | -14.00%144.66M | -8.75%173.74M | -6.02%185.44M | -6.00%171.53M |
| -Notes receivable | -88.16%1.3M | -10.91%5.98M | 1,314.62%10.32M | 894.08%14.81M | 129.07%10.98M | 10.81%6.71M | -95.11%729.28K | -94.08%1.49M | -65.87%4.79M | -36.50%6.06M |
| -Accounts receivable | 18.02%153.59M | -24.12%116.84M | -13.50%124.5M | -34.67%112.53M | -27.96%130.14M | -6.95%153.97M | -6.10%143.93M | 4.24%172.25M | -1.44%180.64M | -4.32%165.47M |
| Other receivables (including interest and dividends) | -18.89%3.11M | -11.50%5.44M | -7.42%5.23M | -39.67%4.68M | -39.46%3.83M | 1.50%6.14M | -5.91%5.65M | 11.85%7.76M | -27.09%6.33M | -25.40%6.05M |
| -Other receivable | ---- | ---- | ---- | -39.67%4.68M | ---- | 1.50%6.14M | ---- | 11.85%7.76M | ---- | -25.40%6.05M |
| Advance payment | 24.54%12.85M | -14.71%8.81M | 86.46%18.47M | 39.81%7.33M | 2.95%10.32M | 17.48%10.33M | -56.05%9.9M | -38.70%5.24M | 15.20%10.02M | 13.28%8.8M |
| Inventories | -12.56%78.97M | -2.79%90.89M | -14.88%78.41M | 18.06%100.62M | 16.37%90.32M | 33.77%93.5M | 12.37%92.12M | 4.61%85.22M | -50.49%77.61M | -53.28%69.9M |
| Receivable financing | 3,879.21%7.96M | 94.53%2.15M | 205.38%4.11M | -42.17%250K | 417.08%200K | --1.11M | -89.09%1.35M | -95.61%432.34K | -99.18%38.68K | ---- |
| Other current assets | -24.58%5.35M | -34.27%4.16M | -29.76%4.46M | 21.53%5.66M | 3,476.31%7.09M | 503.59%6.33M | 387.66%6.35M | 398.31%4.66M | -96.99%198.37K | -89.94%1.05M |
| Total current assets | -1.39%1.14B | -3.83%1.15B | 2.41%1.17B | 0.21%1.18B | -2.56%1.16B | -1.23%1.2B | -5.88%1.14B | -3.16%1.17B | -1.78%1.19B | 1.53%1.21B |
| Non Current assets | ||||||||||
| Long-term equity investment | 0.11%75.3M | -0.12%74.46M | 4.83%77.89M | 4.73%76.48M | 8.38%75.21M | 9.15%74.55M | -34.46%74.3M | -34.94%73.03M | -13.37%69.4M | -16.07%68.3M |
| Fixed assets | ---- | ---- | ---- | -0.92%902.44M | ---- | -4.94%881.66M | ---- | -9.66%910.81M | ---- | -4.47%927.5M |
| Fixed assets liquidation | ---- | ---- | ---- | 1,020.16%435.62K | ---- | 10.95%155.51K | ---- | -70.55%38.89K | ---- | -86.15%140.16K |
| Constru in process | ---- | ---- | ---- | -69.84%16.38M | ---- | 161.90%65.18M | ---- | 402.28%54.31M | ---- | -50.61%24.89M |
| Construction materials | ---- | ---- | ---- | 0.79%1.23M | ---- | 0.04%1.23M | ---- | -15.44%1.23M | ---- | 5.84%1.23M |
| Intangible assets | -4.39%75.96M | -3.44%76.82M | -3.33%77.73M | -3.28%78.6M | -3.24%79.45M | -3.44%79.56M | -3.40%80.41M | -3.37%81.26M | -1.82%82.11M | -2.49%82.39M |
| Goodwill | ---- | ---- | ---- | ---- | ---- | ---- | -94.10%517.42K | -94.10%517.42K | -94.10%517.42K | -94.10%517.42K |
| Deferred tax assets | 80.33%11.86M | 95.39%11.41M | -28.35%8.84M | -37.70%7.6M | -43.85%6.58M | -48.13%5.84M | 35.32%12.34M | 39.69%12.2M | 12.79%11.71M | 15.70%11.26M |
| Other non current assets | 205.46%3.72M | 269.39%6.55M | 307.35%21.19M | -3.19%6.52M | -87.88%1.22M | -89.76%1.77M | 0.04%5.2M | 7.00%6.74M | 70.06%10.04M | -17.61%17.32M |
| Total non current assets | -4.03%1.06B | -5.59%1.05B | -3.78%1.09B | -4.42%1.09B | -3.17%1.1B | -2.08%1.11B | -6.27%1.14B | -8.11%1.14B | -7.25%1.14B | -7.75%1.13B |
| Total assets | -2.68%2.2B | -4.68%2.2B | -0.68%2.26B | -2.07%2.27B | -2.86%2.26B | -1.64%2.31B | -6.08%2.28B | -5.66%2.31B | -4.54%2.32B | -3.18%2.35B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -97.47%745.18K | -98.10%750K | 41.86%28.37M | 67.63%33.53M | 167.48%29.5M | 294.67%39.53M | 100.00%20M | 100.00%20M | 10.29%11.03M | -74.97%10.01M |
| Notes payable and accounts payable | -5.54%113.5M | -6.81%115.57M | 3.10%121.26M | -13.60%112.61M | -9.86%120.16M | -22.80%124.02M | -23.40%117.62M | -7.64%130.34M | -32.13%133.3M | -1.30%160.65M |
| -Notes payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --14.7M | 10,533.33%31.9M |
| -Accounts payable | -5.54%113.5M | -6.81%115.57M | 3.10%121.26M | -13.60%112.61M | 1.31%120.16M | -3.68%124.02M | -4.65%117.62M | 1.73%130.34M | -39.62%118.6M | -20.75%128.75M |
| Contract liabilities | 13.34%25.16M | 4.23%20.1M | 20.17%22.98M | 30.21%15.52M | 28.43%22.2M | 23.68%19.28M | -0.15%19.12M | -33.13%11.92M | -4.98%17.28M | 32.46%15.59M |
| Salaries payable | 7.69%26.16M | -7.09%36.1M | -5.14%31.93M | -6.86%27.2M | -1.77%24.29M | 2.99%38.86M | -5.37%33.66M | -20.23%29.21M | -17.68%24.73M | -12.83%37.73M |
| Taxs payable | 118.60%12.64M | 36.91%12.32M | 20.64%7.27M | -13.41%5.77M | -71.17%5.78M | -12.09%9M | -67.79%6.03M | -35.77%6.66M | 452.44%20.06M | 107.45%10.24M |
| Other payable (including interest and dividends) | -3.07%7.49M | -15.68%7.51M | -12.53%7.26M | -6.74%36.28M | -6.45%7.73M | -44.62%8.9M | -28.98%8.3M | -7.06%38.9M | 16.01%8.26M | 13.56%16.08M |
| -Dividend payable | ---- | ---- | ---- | -1.26%28.91M | ---- | ---- | ---- | -0.63%29.28M | ---- | ---- |
| -Other payable | ---- | ---- | ---- | -23.41%7.37M | ---- | -44.62%8.9M | ---- | -22.36%9.62M | ---- | 13.56%16.08M |
| Other current liabilities | -35.22%5.65M | 32.35%11.58M | 254.65%13.35M | 232.66%13.58M | 67.64%8.73M | 25.86%8.75M | -74.10%3.76M | -82.59%4.08M | -60.01%5.21M | -15.18%6.95M |
| Total current liabilities | -12.38%191.36M | -17.88%203.94M | 11.48%232.43M | 1.40%244.49M | -0.68%218.39M | -3.47%248.34M | -20.79%208.5M | -14.27%241.12M | -21.03%219.88M | -9.78%257.26M |
| Current liabilities | ||||||||||
| Deferred tax liabilities | -57.45%4.35M | -48.81%5.5M | -59.19%8.69M | -58.97%9.27M | -56.48%10.23M | -67.52%10.75M | -37.72%21.3M | -5.23%22.6M | -7.13%23.52M | 33.76%33.09M |
| Long term deferred income | 25.73%8.8M | 24.51%9.28M | -14.85%6.07M | -13.72%6.54M | -13.20%7M | -12.28%7.46M | -22.12%7.13M | -21.89%7.58M | -22.85%8.06M | -24.82%8.5M |
| Total non current liabilities | -23.67%13.15M | -18.78%14.79M | -48.06%14.77M | -47.61%15.81M | -45.43%17.23M | -56.23%18.2M | -34.43%28.43M | -10.05%30.17M | -11.73%31.58M | 15.39%41.59M |
| Total liabilities | -13.21%204.51M | -17.94%218.72M | 4.33%247.2M | -4.05%260.3M | -6.30%235.62M | -10.81%266.55M | -22.72%236.93M | -13.82%271.29M | -19.97%251.46M | -6.95%298.85M |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%294.68M | 0.00%294.68M | 0.00%294.68M | 0.00%294.68M | 0.00%294.68M | 0.00%294.68M | 0.00%294.68M | 0.00%294.68M | 0.00%294.68M | 0.00%294.68M |
| Capital reserve funds | 1.10%722.3M | 1.10%722.3M | 0.01%714.5M | 0.01%714.5M | 0.21%714.44M | 0.21%714.44M | 0.23%714.43M | 0.23%714.43M | 0.02%712.92M | 0.02%712.92M |
| Surplus reserve funds | 0.00%148.68M | 0.00%148.68M | 5.64%148.68M | 5.64%148.68M | 5.64%148.68M | 5.64%148.68M | 0.00%140.73M | 0.00%140.73M | 0.00%140.73M | 0.00%140.73M |
| Retained profit | 0.68%838.54M | -0.77%830.81M | -1.35%833.81M | -1.80%820.81M | -1.01%832.86M | 3.02%837.23M | -3.00%845.26M | -5.13%835.89M | -3.23%841.37M | -4.89%812.69M |
| Less:Treasury stock | 0.00%40.48M | 67.37%40.48M | 67.37%40.48M | 205.94%40.48M | --40.48M | --24.18M | --24.18M | --13.23M | ---- | ---- |
| Other composite income | -11.48%2.12M | -7.09%2.23M | 4.43%2.31M | 1.43%2.37M | 3.49%2.39M | -43.77%2.4M | -65.77%2.22M | -65.48%2.34M | -6.34%2.31M | 26.50%4.27M |
| Specific reserves | 37.75%29.69M | 40.17%28.79M | 7.23%22.92M | 6.51%21.68M | 7.29%21.55M | 10.32%20.54M | 25.90%21.37M | 34.37%20.35M | 52.18%20.09M | 64.21%18.62M |
| Shareholders equity without minority interests | 1.08%2B | -0.34%1.99B | -0.91%1.98B | -1.65%1.96B | -1.89%1.97B | 0.50%1.99B | -2.38%1.99B | -2.73%2B | -1.04%2.01B | -1.66%1.98B |
| Minority interests | -110.51%-4.82M | -110.50%-5.07M | -16.49%38.8M | -8.38%44.04M | -21.51%45.84M | -25.01%48.28M | -38.58%46.46M | -45.02%48.07M | -31.10%58.4M | -24.82%64.38M |
| Total shareholder equity | -1.45%1.99B | -2.94%1.98B | -1.26%2.02B | -1.81%2.01B | -2.44%2.02B | -0.30%2.04B | -3.67%2.04B | -4.46%2.04B | -2.25%2.07B | -2.60%2.05B |
| Total liabilityies and equity | -2.68%2.2B | -4.68%2.2B | -0.68%2.26B | -2.07%2.27B | -2.86%2.26B | -1.64%2.31B | -6.08%2.28B | -5.66%2.31B | -4.54%2.32B | -3.18%2.35B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm